111 (NASDAQ:YI) Trading 2.4% Higher – Should You Buy?

Shares of 111, Inc. Sponsored ADR (NASDAQ:YIGet Free Report) were up 2.4% during trading on Monday . The company traded as high as $8.41 and last traded at $8.38. Approximately 12,303 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 58,331 shares. The stock had previously closed at $8.18.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 111 in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

View Our Latest Stock Analysis on YI

111 Trading Up 2.4%

The stock has a market capitalization of $72.40 million, a P/E ratio of -9.98 and a beta of 0.66. The stock’s fifty day moving average price is $5.26 and its two-hundred day moving average price is $5.05.

111 (NASDAQ:YIGet Free Report) last released its earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The company had revenue of $421.49 million for the quarter.

About 111

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.